OnKure Therapeutics (OKUR) Earnings
OnKure Therapeutics reported on November 4, 2026: EPS of -0.36 against -0.29 expected, a miss.
Summary
In the quarter ended September 2026, OnKure Therapeutics had revenue of —, and diluted EPS of -0.36.
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Last | Wed Nov 4, 2026 | — | -0.29 | -0.36 | Missed |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 2
| Company | Date | Time |
|---|---|---|
| Apple Inc AAPL | Mon Nov 2 | Reported |
| Advanced Micro Devices Inc AMD | Tue Nov 3 | Reported |
| Palantir Technologies Inc. PLTR | Mon Nov 2 | Reported |
| Toyota Motor Corporation ADR TM | Wed Nov 4 | Reported |
| Amgen Inc AMGN | Tue Nov 3 | Reported |
| Arista Networks ANET | Tue Nov 3 | Reported |
| McDonald’s Corporation MCD | Wed Nov 4 | Reported |
| Arm Holdings plc American Depositary Shares ARM | Wed Nov 4 | Reported |
Quarterly results
The last 12 quarters from OnKure Therapeutics's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | — | — | -0.36 | — | — | 2026-11-04 |
| Jun 30, 2026 | — | — | -0.31 | — | — | 2026-08-04 |
| Mar 31, 2026 | — | — | -1.11 | — | — | 2026-05-05 |
| Dec 31, 2025 | — | — | — | — | — | 2026-03-12 |
| Sep 30, 2025 | — | — | -1.09 | — | — | 2025-11-06 |
| Jun 30, 2025 | — | — | -1.14 | — | — | 2025-08-12 |
| Mar 31, 2025 | — | — | -1.19 | — | — | 2025-05-06 |
| Dec 31, 2024 | — | — | — | — | — | 2025-03-10 |
| Sep 30, 2024 | — | — | -36.55 | — | — | 2024-11-07 |
| Jun 30, 2024 | — | — | -44.82 | — | — | 2024-08-13 |
| Mar 31, 2024 | — | — | -30.37 | — | — | 2024-05-07 |
| Sep 30, 2023 | — | — | -5.68 | — | — | 2023-11-13 |
Questions about OnKure Therapeutics
Did OnKure Therapeutics beat earnings estimates?
In its report on November 4, 2026, OnKure Therapeutics missed the EPS estimate: -0.36 reported against -0.29 expected.
How did OnKure Therapeutics do last quarter?
In the quarter ended September 2026, OnKure Therapeutics had revenue of —, and diluted EPS of -0.36.
From OnKure Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.